Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00701-020-04374-x http://scihub22266oqcxt.onion/10.1007/s00701-020-04374-x C7197630!7197630!32367205     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Acta+Neurochir+(Wien) 2020 ; 162 (7): 1491-4 Nephropedia Template TP {{tp|p=32367205|t=2020. SARS-CoV-2 can induce brain and spine demyelinating lesions |pdf=|usr=}}{{32367205}} gab.com Text SARS-CoV-2 can induce brain and spine demyelinating lesions JO: Acta Neurochir (Wien) http://www.kidney.de/pget.php?&tw=1&pmid=32367205 #FOAvip SARS-CoV-2 can attack the central nervous system in the early stages of infection. Headache, anosmia, and dysgeusia are common symptoms. Disturbance of consciousness and seizures can occur as complications in case of severe COVID-19. We described the case of a COVID-19 patient admitted for interstitial pneumonia and seizures. MRI showed newly diagnosed demyelinating lesions. High-dose steroid treatment allowed neurological and respiratory recovery. We speculated a delayed immune response induced by SARS-CoV-2. The virus may lead to a SIRS-like immune disorder or play a role of infective trigger. Prompt invasive treatment should be adopted to avoid hypoxic neurotoxicity and prevent CNS injuries. Twit Text FOAVip SARS-CoV-2 can induce brain and spine demyelinating lesions ????Acta Neurochir (Wien) http://www.kidney.de/pget.php?&tw=1&pmid=32367205 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32367205 #FOAvip English Wikipedia <ref>{{Cite pmid|32367205}}</ref> SARS-CoV-2 can induce brain and spine demyelinating lesions #MMPMID32367205 Zanin L; Saraceno G; Panciani PP; Renisi G; Signorini L; Migliorati K; Fontanella MM Acta Neurochir (Wien) 2020[]; 162 (7): 1491-4 PMID32367205show ga SARS-CoV-2 can attack the central nervous system in the early stages of infection. Headache, anosmia, and dysgeusia are common symptoms. Disturbance of consciousness and seizures can occur as complications in case of severe COVID-19. We described the case of a COVID-19 patient admitted for interstitial pneumonia and seizures. MRI showed newly diagnosed demyelinating lesions. High-dose steroid treatment allowed neurological and respiratory recovery. We speculated a delayed immune response induced by SARS-CoV-2. The virus may lead to a SIRS-like immune disorder or play a role of infective trigger. Prompt invasive treatment should be adopted to avoid hypoxic neurotoxicity and prevent CNS injuries. äSARS-CoV-2 can induce brain and spine demyelinating lesions (epmc).pdf DeepDyve Pubget Overpricing